Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent

Gillian W Reierson, Claudio A Mastronardi, Julio Licinio, Ma-Li WongCenter on Pharmacogenomics, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USAAbstract: Circadian rhythm disturbances can occur as part of the clinical symptoms of major d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gillian W Reierson, Claudio A Mastronardi, Julio Licinio, et al
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://doaj.org/article/caeb08e51ddb44cba701f8a004d22c7a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:caeb08e51ddb44cba701f8a004d22c7a
record_format dspace
spelling oai:doaj.org-article:caeb08e51ddb44cba701f8a004d22c7a2021-12-02T04:21:37ZChronic fluoxetine treatment increases daytime melatonin synthesis in the rodent1179-1438https://doaj.org/article/caeb08e51ddb44cba701f8a004d22c7a2009-09-01T00:00:00Zhttp://www.dovepress.com/chronic-fluoxetine-treatment-increases-daytime-melatonin-synthesis-in--a3520https://doaj.org/toc/1179-1438Gillian W Reierson, Claudio A Mastronardi, Julio Licinio, Ma-Li WongCenter on Pharmacogenomics, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USAAbstract: Circadian rhythm disturbances can occur as part of the clinical symptoms of major depressive disorder and have been found to resolve with antidepressant therapy. The pineal gland is relevant to circadian rhythms as it secretes the hormone melatonin following activation of the cyclic adenosine monophosphate (cAMP) signaling cascade and of arylalkylamine N-acetyltransferase (AA-NAT), the rate-limiting enzyme for its synthesis. Cyclic AMP is synthesized by adenylate cyclases (AC) and degraded by phosphodiesterases (PDEs). Little is known about the contribution of the PDE system to antidepressant-induced alterations in pineal cAMP signaling and melatonin synthesis. In the present study we used enzyme immunoassay to measure plasma melatonin levels and pineal cAMP levels and as well as quantitative real-time polymerase chain reaction to measure pineal expression of PDE, AC, and AA-NAT genes in rats chronically treated with the prototypic antidepressant fluoxetine. We found elevated melatonin synthesis with increased pineal AA-NAT gene expression and daytime plasma melatonin levels and downregulated cAMP signaling with increased PDE and unchanged AC pineal gene expression, and decreased content of pineal cAMP. We conclude that chronic fluoxetine treatment increases daytime plasma melatonin and pineal AA-NAT gene expression despite downregulated pineal cAMP signaling in the rodent.Keywords: antidepressant, melatonin, pineal, nucleotides, cyclic, phosphodiesterase, rat Gillian W ReiersonClaudio A MastronardiJulio Licinioet alDove Medical PressarticleTherapeutics. PharmacologyRM1-950ENClinical Pharmacology: Advances and Applications, Vol 2009, Iss Default, Pp 1-6 (2009)
institution DOAJ
collection DOAJ
language EN
topic Therapeutics. Pharmacology
RM1-950
spellingShingle Therapeutics. Pharmacology
RM1-950
Gillian W Reierson
Claudio A Mastronardi
Julio Licinio
et al
Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent
description Gillian W Reierson, Claudio A Mastronardi, Julio Licinio, Ma-Li WongCenter on Pharmacogenomics, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USAAbstract: Circadian rhythm disturbances can occur as part of the clinical symptoms of major depressive disorder and have been found to resolve with antidepressant therapy. The pineal gland is relevant to circadian rhythms as it secretes the hormone melatonin following activation of the cyclic adenosine monophosphate (cAMP) signaling cascade and of arylalkylamine N-acetyltransferase (AA-NAT), the rate-limiting enzyme for its synthesis. Cyclic AMP is synthesized by adenylate cyclases (AC) and degraded by phosphodiesterases (PDEs). Little is known about the contribution of the PDE system to antidepressant-induced alterations in pineal cAMP signaling and melatonin synthesis. In the present study we used enzyme immunoassay to measure plasma melatonin levels and pineal cAMP levels and as well as quantitative real-time polymerase chain reaction to measure pineal expression of PDE, AC, and AA-NAT genes in rats chronically treated with the prototypic antidepressant fluoxetine. We found elevated melatonin synthesis with increased pineal AA-NAT gene expression and daytime plasma melatonin levels and downregulated cAMP signaling with increased PDE and unchanged AC pineal gene expression, and decreased content of pineal cAMP. We conclude that chronic fluoxetine treatment increases daytime plasma melatonin and pineal AA-NAT gene expression despite downregulated pineal cAMP signaling in the rodent.Keywords: antidepressant, melatonin, pineal, nucleotides, cyclic, phosphodiesterase, rat
format article
author Gillian W Reierson
Claudio A Mastronardi
Julio Licinio
et al
author_facet Gillian W Reierson
Claudio A Mastronardi
Julio Licinio
et al
author_sort Gillian W Reierson
title Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent
title_short Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent
title_full Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent
title_fullStr Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent
title_full_unstemmed Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent
title_sort chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent
publisher Dove Medical Press
publishDate 2009
url https://doaj.org/article/caeb08e51ddb44cba701f8a004d22c7a
work_keys_str_mv AT gillianwreierson chronicfluoxetinetreatmentincreasesdaytimemelatoninsynthesisintherodent
AT claudioamastronardi chronicfluoxetinetreatmentincreasesdaytimemelatoninsynthesisintherodent
AT juliolicinio chronicfluoxetinetreatmentincreasesdaytimemelatoninsynthesisintherodent
AT etal chronicfluoxetinetreatmentincreasesdaytimemelatoninsynthesisintherodent
_version_ 1718401335421829120